Lakefront Biotherapeutics N.V.
Status: Publicly traded
Direct answer
Lakefront Biotherapeutics N.V. is publicly traded on NASDAQ under the ticker LKFT.
Lakefront Biotherapeutics NV, a biotechnology company, develops medicines focusing on oncology and immunology primarily in the United States and Europe. The company's pipeline products comprise GLPG3667, which is in a phase 2 clinical trial in dermatomyositis and systemic lupus erythematosus; GLPG5101, a CD19 CAR-T product candidate manufactured at point-of-care, currently in a phase 1/2 trial in relapsed/refractory...
Can you invest in Lakefront Biotherapeutics N.V.?
Yes. Lakefront Biotherapeutics N.V. trades publicly on NASDAQ as LKFT.
View deeper analysis
View detailed research on MarketSnap, including financials, valuation tools, and analyst context.
Open research for Lakefront Biotherapeutics N.V.
Detailed equity research is provided by MarketSnap.